Financials Dyadic International, Inc.

Equities

DYAI

US26745T1016

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.49 USD 0.00% Intraday chart for Dyadic International, Inc. -6.29% -7.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 141 147.9 126.9 35.13 46.39 43.56 -
Enterprise Value (EV) 1 141 147.9 126.9 35.13 46.39 43.56 43.56
P/E ratio -16.7 x -15.8 x -9.62 x -3.62 x -6.71 x -2.26 x -1.66 x
Yield - - - - - - -
Capitalization / Revenue 83.9 x 92.3 x 52.8 x 12 x 16 x 10.4 x 7.14 x
EV / Revenue 83.9 x 92.3 x 52.8 x 12 x 16 x 10.4 x 7.14 x
EV / EBITDA - - -11,392,519 x - - - -
EV / FCF - - -11,254,620 x - - - -
FCF Yield - - -0% - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 27,213 27,482 28,079 28,563 28,811 29,237 -
Reference price 2 5.180 5.380 4.520 1.230 1.610 1.490 1.490
Announcement Date 3/30/20 3/30/21 3/29/22 3/29/23 3/28/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1.681 1.602 2.404 2.93 2.899 4.2 6.1
EBITDA - - -11.14 - - - -
EBIT 1 -9.283 -10.03 -14.73 -10.17 -8.23 -23.2 -28.8
Operating Margin -552.18% -625.85% -612.67% -346.92% -283.9% -552.38% -472.13%
Earnings before Tax (EBT) 1 -8.298 -9.294 -13.07 -9.735 -6.795 -22.7 -28.3
Net income 1 -8.308 -9.325 -13.07 -9.735 -6.795 -22.7 -31.3
Net margin -494.2% -582.13% -543.73% -332.23% -234.42% -540.48% -513.11%
EPS 2 -0.3100 -0.3400 -0.4700 -0.3400 -0.2400 -0.6600 -0.9000
Free Cash Flow - - -11.28 - - - -
FCF margin - - -469.12% - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/30/20 3/30/21 3/29/22 3/29/23 3/28/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 0.6929 0.3133 0.6484 0.6586 0.8796 0.7437 - 0.8372 0.3971 0.6865
EBITDA - - - - - - - - - -
EBIT 1 -3.324 -4.216 -2.745 -3.318 -1.863 -2.24 - -2.29 -1.72 -2.169
Operating Margin -479.7% -1,345.65% -423.27% -503.83% -211.85% -301.13% - -273.6% -433.21% -315.89%
Earnings before Tax (EBT) 1 -1.715 -4.214 -2.492 -3.288 -1.809 -2.146 - -2.153 -1.614 -2.072
Net income 1 -1.715 -4.214 -2.492 -3.288 -1.809 -2.146 -0.9564 -2.153 -1.614 -2.072
Net margin -247.54% -1,345.03% -384.26% -499.28% -205.68% -288.6% - -257.17% -406.55% -301.77%
EPS 2 -0.0600 -0.1500 -0.0900 -0.1200 -0.0600 -0.0700 -0.0300 -0.0700 -0.0600 -0.0800
Dividend per Share - - - - - - - - - -
Announcement Date 11/10/21 3/29/22 5/12/22 8/10/22 11/10/22 3/29/23 5/10/23 8/9/23 11/8/23 3/28/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - -11.3 - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 3/30/20 3/30/21 3/29/22 3/29/23 3/28/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.49 USD
Average target price
7.5 USD
Spread / Average Target
+403.36%
Consensus
  1. Stock Market
  2. Equities
  3. DYAI Stock
  4. Financials Dyadic International, Inc.